Research Article
The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
Figure 4
Calibration curves for predicting the 3-year and 5-year OS of HCC patients receiving RFA. Calibration curves for predicting the 3-year and 5-year OS in the training cohort (a, b) and validation cohort (c, d). Abbreviations: HCC: hepatocellular carcinoma; RFA: radiofrequency ablation; OS: overall survival.
(a) |
(b) |
(c) |
(d) |